BeStock  
Stocks › CAR-T Therapy › NVS

Novartis AG NVS

US equityMarket cap rank #46CAR-T TherapyCancer Research
$162.55 +$0.62 (+0.38%)
Market closed · Nov 6, 8:20 pm ET · Last extended-hours $162.55 0.00%
Open$159.40
Prev close$161.93
Day range$159.36 – $163.11
Volume2.00M
Market cap$307.00B
P/E (TTM)31.0
Dividend yield2.92%

Analyst view

ConsensusBuy
Analysts3
Average target$171.50+5.5% vs. price
  • Buy 67%
  • Hold 33%
Low $163.00Now $162.55Avg $171.50High $180.00

Recent rating changes

The last 20 actions on file set price targets from $148.08 to $185.00, averaging $171.76.

DateFirmRatingTarget
28 Oct 2026 Morgan Stanley BUY $163.00
27 Oct 2026 BofA Securities BUY –
12 Oct 2026 BofA Securities BUY $185.00
6 Oct 2026 Morgan Stanley BUY $156.00
5 Oct 2026 BofA Securities BUY –
8 Sep 2026 TD Cowen HOLD $180.00
7 Sep 2026 BofA Securities BUY $180.87
1 Sep 2026 BofA Securities BUY $172.75
27 Jul 2026 TD Cowen HOLD $180.00
24 Jul 2026 Argus Research BUY $170.00
21 Jul 2026 BofA Securities BUY –
11 Jun 2026 TD Cowen HOLD $180.00
11 Jun 2026 BofA Securities BUY $173.29
4 Jun 2026 Argus Research BUY $160.00
18 May 2026 TD Cowen HOLD $148.08
27 Mar 2026 BofA Securities BUY $175.37
26 Mar 2026 Morgan Stanley BUY $170.00
24 Mar 2026 BofA Securities BUY $176.12
23 Mar 2026 BofA Securities BUY $177.65
19 Mar 2026 Bernstein HOLD –

Discussion

No comments yet — be the first to weigh in on NVS.

Sign in to join the discussion.

Scroll to Top